ClinicalTrials.Veeva

Menu

Medication Reconciliation in Comparison to an Extensive Medication Safety Check

R

RWTH Aachen University

Status

Completed

Conditions

Adverse Drug Event
Elderly

Treatments

Other: Medication Reconciliation
Other: Pharmaceutical Care

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine wether an extensive medication safety check has a greater impact on the incidence of adverse drug events than medication reconciliation or no intervention.

Enrollment

220 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient 65 years and older
  • written informed consent patient or the legal representative
  • existing medication therapy at hospitalization
  • admission to one of the project wards via emergency department (non elective)

Exclusion criteria

  • patients included in the study previously

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

220 participants in 3 patient groups

Controll-Group
No Intervention group
Description:
Patient randomized to the Control-Group will receive the traditional care by physician and nurse on the ward.
MedRec-Group
Experimental group
Description:
Patient randomized to the MedRec-Group will receive the traditional care by physician and nurse on the ward and additional pharmacist led medication reconciliation.
Treatment:
Other: Medication Reconciliation
AMTS-Group
Experimental group
Description:
Patient randomized to the AMTS-Group will receive the traditional care by physician and nurse on the ward and additional pharmaceutical care by a pharmacist.
Treatment:
Other: Pharmaceutical Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems